Primary oncocytic adenocarcinomas of the lung: A clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases

American Journal of Clinical Pathology

Volumn 133, Issue 1, 2010, Pages 133-140

  Solis, Luisa M ^a   Raso, M Gabriela ^a   Kalhor, Neda ^a   Behrens, Carmen ^a   Wistuba, Ignacio I ^a   Moran, Cesar A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adenocarcinoma; Carcinoma; Immunohistochemistry; Lung; Oncocytic

Indexed keywords

CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR; K RAS PROTEIN; MITOCHONDRION ANTIBODY; THYROID TRANSCRIPTION FACTOR 1;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DYSPNEA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; MALE; MOLECULAR BIOLOGY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THORAX PAIN;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FATAL OUTCOME; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OXYPHIL CELLS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 73949135041     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPOQWPT1T1AJFT     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Moran CA. Pulmonary adenocarcinoma: the expanding spectrum of histologic variants. Arch Pathol Lab Med. 2006;130:958-962.
3. Moran CA. Mucin rich tumors of the lung. Adv Anat Pathol. 1995;2:299-305.
4. Graeme-Cook F, Mark EJ. Pulmonary mucinous cystic tumors of borderline malignancy. Hum Pathol. 1991;22:185-190.
5. Moran CA, Hochholzer L, Fishback N, et al. Mucinous (so-called colloid) carcinoma of the lung. Mod Pathol. 1992;5:634-638.
6. Silver S, Askin FB. True papillary carcinoma of the lung: a distinct clinicopathologic entity. Am J Surg Pathol. 1997;21:43-51.
7. Moran CA, Jargidar J, Suster S. Papillary lung adenocarcinoma with prominent "morular" component. Am J Clin Pathol. 2004;122:106-110.
8. Amin M, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358-364.
9. Kish JK, Ro JY, Ayala AG, et al. Primary mucinous adenocarcinoma of the lung with signet-ring cells: a histochemical comparison with signet-ring cell carcinomas of other sites. Hum Pathol. 1989;20:1097-1102.
10. Castro CY, Moran CA, Flieder DG, et al. Primary signet ring cell adenocarcinoma of the lung: a clinicopathological study of 15 cases. Histopathology. 2001;39:397-401.
11. Steinhauer JR, Moran CA, Suster S. "Secretory endometrioid- like" adenocarcinoma of the lung [letter]. Histopathology. 2005;47:219-220.
12. Ishikura H, Kanda M, Ito M, et al. Hepatoid adenocarcinoma: a distinctive histological subtype of alpha-fetoprotein-producing lung carcinoma. Virchows Arch A Pathol Anat Histopathol. 1990;417:73-80.
13. Hayashi Y, Takanashi Y, Ohsawa H, et al. Hepatoid adenocarcinoma of the lung. Lung Cancer. 2002;38:211-214.
14. Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004.
15. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutation in lung cancers. J Natl Cancer Inst. 2005;97:339-346.
16. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res. 2005;65:7568-7572.
17. Sklar JL, Churg A, Bensh KG. Oncocytic carcinoid tumor of the lung. Am J Surg Pathol. 1980;4:287-292.
18. Aubertine CL, Flieder DB. Primary paraganglioma of the lung. Ann Diagn Pathol. 2004;8:237-241.
19. Fechner RE, Bentnick BR. Ultrastructure of bronchial oncocytoma. Cancer. 1973;331:1451-1457.
20. Santos-Bris A, Jenron J, Sastre R, et al. Oncocytoma of the lung. Cancer. 1977;40:1330-1336.
21. Moran CA, Suster S, Koss MN. Acinic cell carcinoma of the lung ("Fechner tumor"): a clinicopathologic, immunohistochemical, and ultrastructural study of five cases. Am J Surg Pathol. 1992;16:1039-1050.
22. Nishioka H, Hirano A, Haraoka J, et al. Histological changes in the pituitary gland and adenomas following radiotherapy. Neuropathology. 2002;22:19-25.
23. Muller-Hocker J. Random cytochrome-C-oxidase deficiency of oxyphil cell nodules in the parathyroid gland: a mitochondrial cytopathy related to cell aging. Pathol Res Pract. 1992;188:701-706.
24. Tallini G. Oncocytic tumors. Virchows Arch. 1998;433:5-12.
25. Sobrinho-Simoes M, Maximo V. Warthin's tumor [letter]. Virchows Arch. 2006;448:877-878.
26. Teymoortash A, Werner JA. Tissue that has lost its track: Warthin's tumor. Virchows Arch. 2005;446:585-588.
27. Ambrosini-Spaltro A, Salvi F, Betts CM, et al. Oncocytic modifications in rectal adenocarcinoma after radio and chemotherapy. Virchows Arch. 2006;448:442-448.